Longtime insurance watchdog ends 40-year-old newsletter
The Insurance Forum, an independent newsletter based in central Indiana and read by industry leaders and consumer advocates across the continent, has placed its last issue in the mail.
Health Care & Insurance
Articles
Indiana insurance department studying Obama proposal
Chief Deputy Insurance Commissioner Logan Harrison says the Department of Insurance doesn't yet know whether state regulators have the legal authority to approve reversals.
Obamacare has many health care insurers worried
The messy rollout of the insurance exchanges has made it hard for carriers to figure out what business will be like in 2014.
Obama allows customers to keep canceled policies
Bowing to pressure, President Barack Obama on Thursday announced changes to his health care law to give insurance companies the option to keep offering consumers plans that would otherwise be canceled.
Lilly to spend another $700M in growing market for diabetes products
The move includes a $45 million investment for Lilly's operations in Indianapolis, on top of $400 million in investments the company announced over the past two years.
701 Hoosiers choose Obamacare plans at rollout
The administration says fewer than 27,000 people managed to enroll for health insurance last month in the 36 states relying on the problem-filled federal website for President Barack Obama’s overhaul.
Lilly pledges up to $1.8B to Pfizer for access to potential blockbuster
Eli Lilly and Co. and Pfizer Inc., which are both suffering through some of the largest patent cliffs in the industry, will split any future costs and profits of an osteoarthritis drug that has stalled in clinical testing.
Smoking ban opens new doors to Visit Indy
New convention prospects are talking to the city’s marketing agency after passage of the city’s expanded smoking ordinance last year.
Testosterone drugs raise heart risk, study finds
Testosterone replacement drugs, a $1.6 billion market for Eli Lilly and Co. and others, boosted the odds of having a heart attack, stroke or dying by 29 percent in one of the first studies weighing the therapy's cardiovascular risks.
Lilly a possible suitor for Novartis AG’s animal-health unit
Indianapolis-based Eli Lilly and Co., Bayer AG and Boehringer Ingelheim GmbH are among companies that may consider an offer if the Swiss drugmaker proceeds with the animal-health sale.
Lawmakers considering more changes to patent laws
U.S. lawmakers, influenced by companies including Indianapolis-based Eli Lilly and Co., Cisco Systems Inc. and Qualcomm Inc., are considering the second set of patent-law changes in three years as the courts try to race ahead of Congress.
State: It’ll be Christmas before we can talk to Obamacare website
Indiana officials don’t expect HealthCare.gov to be able to share individual account information with the state’s Medicaid computer systems until the end of the year.
With Obamacare, insurers will still find ways to avoid risk
Obamacare put an end to health insurers’ worst methods for avoiding risk. But that doesn’t mean insurers have ended their risk-shifting ways. Not at all.
State extends high-risk pool because of Obamacare woes
State officials announced Thursday that they will extend Indiana’s high-risk insurance pool through the end of January to accommodate Hoosiers who have been unable to enroll in coverage through the federal marketplace.
The bill for Hoosiers’ excess health care spending: About $5 billion per year
Hoosiers’ poor health, combined with an aggressive health care system and an uncompetitive health insurance sector, means Hoosiers, in spite of the fact that they earn just 86 cents for every dollar earned by the average American, are spending nearly $1.13 on health care for every dollar spent by Americans.
‘Zero-premium’ insurance could leave hospitals hurting
So-called “zero-premium plans” are priced in such a way that their premiums would be no greater than the federal tax subsidies that low-income buyers could claim.
The frightening future that’s haunting hospitals
Why are Indiana’s hospitals cutting jobs. Because they’re spooked about cuts to Medicare payments. They should be.
Baldwin & Lyons’ profit falls on smaller investment gains
Premiums written by the firm’s insurance subsidiaries hit $96.6 million, an increase of nearly 19 percent over the third quarter a year ago and 4 percent over the second quarter.
MILLER: Specialty medications have potential to cut costs
Today’s specialty medications are modern miracles, helping millions of patients with chronic, life-threatening illnesses such as cancer, multiple sclerosis and rheumatoid arthritis.
Purdue makes big push into state’s pharma industry
With a $60 million-plus investment, the university aims to take molecules from discovery to clinical trials.